EGFR and cancer: In the enrichment analysis conducted in this study, the TFs and miRNAs identified as major regulators in the FFLs were shown to be involved in critical cancer-associated signaling pathways, such as the, ER, ERBB, FOXO, HIPPO, P53, PTEN RAP1, and TGF-beta pathways.